Avoro Capital Advisors 13F: Exits TRML Stake

Avoro Capital Advisors has fully exited its position in TRML, selling all 2.56 million shares.

Reviewed by automated data checks against the source filing. How we make and check alerts

Avoro Capital Advisors sold its entire stake of 2,555,555 shares in TRML ($TRML), according to a 13F filing with the SEC dated February 17, 2026.

Find the original: Avoro Capital Advisors 13F filings on SEC EDGAR

Key Points

  • Avoro Capital Advisors sold its entire stake of 2.56 million shares in TRML, reflecting a 100% reduction.
  • Multiple insiders, including the CBO and Chief Technology Officer, sold shares of TRML on October 28, 2025.
  • Several analysts downgraded TRML to a hold rating in September 2025, setting a price target of $48.

Get $TRML trade alerts by text

We text you when insiders, Congress or big funds trade $TRML. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated TRML alert may contain errors. Disclosures

Avoro Capital Advisors has completely exited its position in TRML. According to its latest filing with the SEC, the firm sold its entire holding of 2,555,555 shares. This move reflects a 100% reduction from its prior stake.

What Changed in Avoro Capital Advisors' TRML Position

Avoro Capital Advisors had previously held 2,555,555 shares of TRML. As of the latest filing, the firm has sold all its shares, marking a complete exit from the stock. The exact value of the sale wasn't disclosed.

Insider Buying and Selling at TRML

Insider activity at TRML shows significant selling activity on October 28, 2025. Bradford Middlekauff, the Chief Business Officer and General Counsel, sold 60,988 shares. Sapna Srivastava sold 46,800 shares, while Susan Dana Jones, the Chief Technology Officer, sold 3,152 shares. Additionally, Kevin Bruce Johnson, the Chief Regulatory Officer, sold 11,046 shares, and Caley Castelein sold 36,800 shares. These transactions were not part of a pre-planned trading program.

Analysts Set New Price Targets

Several analysts downgraded TRML to a hold rating in September 2025. BMO Capital, Piper Sandler, Truist Securities, Guggenheim, HC Wainwright & Co., and Chardan Capital all set a price target of $48. Meanwhile, Jefferies set its target slightly lower at $47.5. These downgrades suggest a cautious outlook on the stock.

Bottom Line

Avoro Capital Advisors' decision to sell its entire stake in TRML is noteworthy, as it reflects a significant shift in its investment strategy. Insider selling and analyst downgrades further highlight the cautious sentiment surrounding TRML. It's important to remember that 13F filings are backward-looking and may not reflect current positions. Investors often track such filings to gauge institutional sentiment and potential market movements.

Source: Avoro Capital Advisors's 13F filing on $TRML (Feb 17, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Avoro Capital Advisors 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $TRML trade alerts by text